ASHP InterSections ASHP InterSections

June 1, 2017

Celebrating Former ASHP CEOs: Joseph A. Oddis, Sc.D. (Hon.)

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

ON MAY 19, the ASHP family celebrated the dedication of our new offices — the Joseph A. Oddis Global Headquarters of ASHP — named for the organization’s second and longest-serving CEO. It’s fitting that Dr. Oddis’ name graces our offices as we mark the beginning of a new era for ASHP. A visionary leader, he has had a profound and lasting impact on ASHP and the creation of modern clinical pharmacy practice and, undoubtedly, has improved patient care and public health.

Nearly six decades ago, in 1960, Dr. Oddis took over the helm of ASHP, known then as the American Society of Hospital Pharmacists. During his 37-year tenure as CEO, he transformed ASHP from an organization with 3,300 members and one staff person — Dr. Oddis — into a strong, vibrant, and influential force in pharmacy and healthcare. Under his leadership, ASHP grew to more than 31,000 members and 180 employees. Today, ASHP has nearly 45,000 members, a staff of more than 200, and a wide range of contributions that would not have been possible without Dr. Oddis’ extraordinary vision and tremendous leadership.

Joseph A. Oddis, (center) celebrates the dedication of ASHP’s new headquarters offices named in his honor. Dr. Oddis is joined by (from left) ASHP CEO Paul W. Abramowitz, son Joseph M. Oddis, granddaughter Rebecca Newman, daughter-in-law Debra Oddis, son-in-law Richard Newman, and ASHP President Lisa Gersema.

Dr. Oddis’ most enduring legacy is the ASHP family. A warm and generous leader, he took care to cultivate a staff culture that focused on serving our members in a respectful, team-based approach. He is a man of great humility who never sought the limelight. As ASHP grew and achieved renown, Dr. Oddis always credited staff, volunteer leaders, and members for the organization’s success.

Many of ASHP’s signature initiatives can be traced to Dr. Oddis’ leadership, including the accreditation of pharmacy residencies, the creation of education and certification programs for pharmacy technicians, and the expansion of continuing education opportunities for pharmacists with the conferences that would become the ASHP Summer Meetings and the award-winning Midyear Clinical Meeting.

Dr. Oddis was an early advocate for pharmacists as patient care providers on interprofessional teams and drove efforts to improve global pharmacy. In 1968, he established the ASHP Foundation, whose extensive research, educational, and awards programs make it a key partner for ASHP in driving pharmacy practice forward into a new and better future.

Under Dr. Oddis’ direction, ASHP cultivated our core strength in drug information and introduced the American Hospital Formulary Service, which has gained international recognition as the most comprehensive source of unbiased drug information. ASHP has also published hundreds of clinical and professional books that — taken together with our flagship publication, AJHP— provide pharmacists around the world with a vast, in-depth library of information to enhance their patient care services.

Dr. Oddis (center) with ASHP Past Presidents (from left) Gerald E. Meyer, Thomas S. Thielke, Janet A. Silvester, Steven L. Sheaffer, Marianne F. Ivey, Paul W. Abramowitz, Rebecca S. Finley, Philip J. Schneider, Fred M. Eckel.

Dr. Oddis is a man of incomparable grace, wisdom, and vision. When I served on the ASHP Board of Directors and as ASHP President in the early ’90s, I had the great pleasure to work very closely with Dr. Oddis. He was a mentor to me, as all of the ASHP presidents can attest, and I still seek his counsel and advice today. I am indebted to him and honored to follow in his footsteps.

Our new headquarters not only carries Dr. Oddis’ name, but also embodies a principle he emphasized during his time as CEO: ASHP headquarters is more than a building. It is the heart of our professional association, and it reflects the success of our members in providing care to the patients that you serve.

We are grateful to Dr. Oddis for that lesson and so many others. And we look forward to continuing his tremendous legacy during our 75th anniversary and for many years to come in the newly minted Joseph A. Oddis Global Headquarters of ASHP.

Sincerely,

Paul

April 13, 2017

Celebrating Former ASHP CEOs: Henri R. Manasse Jr., Ph.D., Sc.D. (Hon.), FFIP

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

AS PART OF ASHP’s yearlong 75th anniversary celebration, I will be recognizing our three former Chief Executive Officers: Drs. Henri R. Manasse Jr., Joseph A. Oddis, and Gloria Francke. This blog will recognize our most recent CEO, Dr. Manasse, who served ASHP from 1997 to 2011.

Dr. Manasse came to ASHP after a long and illustrious career as a leader in academic healthcare. He was Vice President for Health Sciences at The University of Iowa and Chairman of the Board of the University of Iowa Health System. Prior to that, he was interim Vice Chancellor for Health Services at the University of Illinois at Chicago Medical Center, and Dean and Professor of Pharmacy Administration at the University of Illinois at Chicago College of Pharmacy. In 1988 he served as president of the American Association of Colleges of Pharmacy. He is also a member of the prestigious National Academy of Medicine (formally the Institute of Medicine) of the National Academy of Sciences and a recipient of pharmacy’s highest honor, the Harvey A.K. Whitney Lecture Award.

Dr. Manasse came to ASHP during a time of transition and change, and he helped the society become an even more outward-facing organization. Under his leadership, ASHP became increasingly engaged in proactive government advocacy and formed strong relationships with a wide variety of stakeholders in medicine, nursing, standards-setting bodies, hospital organizations, payers, and many others. He played a vital role after the 1999 Institute of Medicine Report, “To Err is Human,” to take ASHP’s longtime focus on patient safety, and work with stakeholders in all segments of society to help drive fundamental changes that have helped improve patient safety throughout the entire healthcare system.

In 2006 he served as Chair of the Board of Governors of the National Patient Safety Foundation and co-chaired the Safe Practices Steering Committee and the Advisory Committee for Executive Leadership of the National Quality Forum. He also chaired The Joint Commission’s Sentinel Event Alert Advisory Committee and served on the U.S. Food and Drug Administration’s Drug Safety and Risk Management Advisory Committee. In 2005, he was elected as the Professional Secretary of the Board of Pharmaceutical Practice of the International Pharmaceutical Federation. He also served on the Board of Advisors of the Association of Academic Health Centers project on the Future of the Health Professions Work Force.

Dr. Manasse’s time as CEO was also a period of growth for ASHP in numerous areas including membership, educational conferences, residency accreditation, publishing, and many others. He also oversaw the formation of many of ASHP’s highly successful pharmacy practice sections and forums, which include the Sections of Clinical Specialists and Scientists, Ambulatory Care Practitioners, Pharmacy Informatics and Technology, Inpatient Care Practitioners, Pharmacy Practice Managers, and the Student and New Practitioners Forums.

Henri was and still is a strong advocate for the leadership roles that pharmacists play as direct patient care providers. He has been a longtime advocate for the enhanced roles that educated, PTCB certified, and licensed pharmacy technicians must play to ensure that all patients have access to a pharmacist on the interprofessional team who is responsible for their medication therapy. Dr. Manasse has dedicated his nearly 50-year career to continuously elevating the entire pharmacy profession with the singular goal of ensuring that medication use is optimal, safe, and effective for all people all of the time.

I had the pleasure of chairing the ASHP CEO Search Committee that led to Dr. Manasse’s selection and later serving as Treasurer of ASHP during Henri’s time as CEO. Our time together and ongoing friendship is something that I will always value. Henri is a true leader and has been a mentor to countless pharmacists, student pharmacists, ASHP staff members, board members, and many others.

As we celebrate ASHP’s 75th anniversary, please join me in thanking Dr. Manasse for his exceptional contributions to ASHP and to the entire pharmacy profession.

Sincerely,

Paul

March 27, 2017

ASHP’s 75th Anniversary: Celebrating the Past, Creating the Future

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

ASHP TURNS 75 THIS YEAR, and we have a yearlong campaign filled with surprises and exciting events for our members to celebrate this significant milestone. The last 75 years have been marked by so many ASHP-led advances in pharmacy practice, including: the creation of postgraduate residency training, clinical pharmacy, enhanced recognition of pharmacists as vital members of the interprofessional team, the largest gathering of pharmacists in the world — the ASHP Midyear Clinical Meeting — and so many more.

Although much has been accomplished over the last 75 years, our focus remains on the future, and ensuring that more and more people have access to the direct patient care services of pharmacists. Therefore, the theme of our yearlong celebration is Celebrating the Past, Creating the Future.

The founders of ASHP were visionaries who understood and learned from the past but realized that pharmacists must transform their practices. They worked hard to create a practice future designed to dramatically improve the care of their patients. These leaders included legends such as Gloria Niemeyer Francke, ASHP’s first CEO; Harvey A.K. Whitney, ASHP’s first president; and Donald Francke, ASHP’s second president; and, of course, Joseph A. Oddis, ASHP’s CEO for over 37 years. These are just a few of the great leaders who realized very early that pharmacists must do so much more than dispense drugs, and that ASHP should be the organization that makes it happen on behalf of patients.

Prior to the 1920s, hospital pharmacy was not a strong, well-organized component of the profession. In 1936, a subsection of hospital pharmacists in APhA was formed and, for the first time, hospital pharmacists had a voice on the national pharmacy stage. In 1942, the American Society of Hospital Pharmacists was formed with 153 charter members who worked exclusively in hospital settings.

Today ASHP has nearly 45,000 members who treat patients in every healthcare setting, including in ambulatory clinics, hospitals, and throughout the entire continuum of patient care. ASHP members are involved in all facets of pharmacy practice and include inpatient pharmacists, ambulatory care pharmacists, clinical specialists and scientists, informatics experts, practice managers, student pharmacists, residents, new practitioners, pharmacy technicians, and others.

We owe our success to our dedicated members, which is why we would like you to help us celebrate our diamond anniversary. We have a number of special activities scheduled throughout the year, culminating in a grand finale celebration at the Midyear Clinical Meeting in Orlando in December. We also are planning significant activities for key ASHP events including the Summer Meetings in June, the Preceptors Conference in August, Policy Week in September, and the Leaders Conference in October.

Thank you so much for being a member of ASHP, and for everything you do for your patients. With your help, we can continue to improve patient care and support you in your professional endeavors.

Please join us in celebrating this important anniversary — and stay tuned for more details as we roll out our 75th anniversary celebration.

Sincerely,

Paul

March 17, 2017

Residency Match Day 2017

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

CONGRATULATIONS TO ALL WHO MATCHED during Phase I of the residency Match! If you didn’t match in the first round, please plan to participate in Phase II, as there are still a number of unfilled positions at excellent programs all across the country.

This year’s Match was another remarkable success. There were 5,752 applicants this year for 4,592 residency positions. Of those total positions, 3,750 are now filled with the remainder to be filled in Phase II of the Match. It should be noted that over the last five years residency positions have increased by 1,594.

It is wonderful to see such incredible interest in residency training and how the profession is responding to the increased demand by adding new positions. Residency training is an opportunity for pharmacists to further distinguish themselves as the medication experts on the patient care team, and expand their role in overall patient care.

ASHP, under the leadership of former CEO Dr. Joseph A. Oddis, created the concept of residency training and began accrediting programs 55 years ago. ASHP’s leadership in this area planted the seed for the formation of clinical pharmacy practice. Today, residency training and clinical pharmacy are more important than ever, and patients everywhere are benefiting from these important advances in pharmacy practice.

PGY2 ambulatory care residencies have experienced dramatic growth in recent years. Two years ago, there were 83 residency programs in ambulatory care; today there are 137 programs. Compared to last year, PGY2 residency programs in the areas of emergency medicine, infectious disease, and psychiatric care have also expanded rapidly.

The significant increase in the number of PGY2 residencies indicates that the market is demanding highly trained pharmacists for specialty areas of practice. In addition, the rising support for provider status at the state and national levels, as well as other changes to the healthcare landscape, is creating a demand for more residency programs.

Participating in residency programs is a win-win for you, your patients, and for the profession. I know that all of you as new PGY1 and PGY2 residents will rise up to meet the many challenges of completing a residency, and the experience will prepare you to practice at a higher level as a vital member of an interprofessional team.

Know that regardless of where you practice — whether in an ambulatory clinic, hospital, or other patient care setting — ASHP is your professional home as a patient care provider. Please plan to continue to read and contribute to AJHP Residents Edition. ASHP is the only organization with this exceptional peer-reviewed platform for pharmacy residents, and its success is fully attributed to you and the great work you will be doing as a resident. During your residency, keep up with best practices in research by viewing the ASHP Foundation’s The Essentials of Practice-Based Research. Please also make sure to stay involved in the ASHP New Practitioners Forum, which provides a multitude of resources and opportunities, including in-depth information about preparing for career transitions.

Again, congratulations to all of you, and good luck in your residency. I look forward to seeing you at the ASHP Midyear Clinical Meeting and Exhibition in Orlando in December!

Sincerely,

Paul

May 26, 2016

ASHP Building Update (May 2016)

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

IT IS MY PLEASURE to announce that ASHP has sold our headquarters building at 7272 Wisconsin Avenue in Bethesda, Md., and will be moving to a wonderful new building just a few blocks away early next year.

ASHP has been in our current headquarters — The Joseph A. Oddis Building — since we purchased it in 1992. Since that time, ASHP has grown dramatically, and so has downtown Bethesda. It’s because of this growth and change that we decided to sell our building.

For some time now, the state of Maryland and surrounding counties have envisioned a new east-west train line that would better connect commuters and visitors to key parts of the Washington, D.C., metro area, including Bethesda. After many years, the funding for this new Purple Line is now secured, and building on the new line is projected to start in the next few years. ASHP fits into this story because our current building in the heart of downtown Bethesda sits on the location of the proposed new Metro Purple Line Station, on a piece of real estate that is ripe for a major new downtown development.

The Joseph A. Oddis Building

The Joseph A. Oddis Building

Because of the decision to sell our building, ASHP will be able to move into a new headquarters that is modern and environmentally friendly, a headquarters that will accommodate our growing membership and staff, provide enhanced capabilities and resources to help us better serve our members, and advance our public health mission.

Our space in this new building is currently being constructed, and I look forward to sharing some images with you once it’s completed. I also welcome you to come tour our new space if you’re ever in town visiting or serving on an ASHP member committee. ASHP is your professional home, and we would love to see you!

I would like to recognize my predecessor, Dr. Joseph A. Oddis, for his vision and subsequent decision to purchase the ASHP building well before Bethesda experienced such explosive growth. It’s fair to say that, without him, ASHP would not be in the position it is today as the best and fastest growing pharmacy organization in the world.

ASHP's new headquarters building

ASHP’s new headquarters building

I hope that you share our excitement as we move to ASHP’s new home. Most importantly, I want to thank all of you — our members — for everything that you do for your patients and the profession. It’s because of you that ASHP continues to grow and excel. I look forward to updating you in the coming months about our forthcoming move to our new headquarters, and continuing to share updates on the exceptional resources ASHP provides to advance your practice.

Have a wonderful day, and thank you so much for being a member of ASHP!

Sincerely,

Paul

February 11, 2013

ASHP Headquarters Named to Honor Dr. Joseph A. Oddis

Filed under: From the CEO,Home — Tags: , , , — jmilford @ 10:30 am

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

TODAY, I AM PLEASED TO MAKE a very special announcement to the members of ASHP.

At its January meeting, the Board of Directors voted unanimously to name the ASHP headquarters building, here at 7272 Wisconsin Avenue in Bethesda, Md., after the man who led our organization for 37 years: Dr. Joseph A. Oddis.

As of now, the headquarters of ASHP will be known as the Joseph A. Oddis Building. The building will be dedicated at a ceremony to be held this spring.

There could not be a more fitting person to receive this honor. Dr. Oddis’ leadership over nearly four decades helped make ASHP the strong, vibrant, growing, and influential organization it is today. Joe’s vision for what ASHP could be and the important role we could play in shaping pharmacy practice, improving patient care, and influencing public policy to improve public health set this organization on the path it still follows today.

Here are just a few significant achievements from Dr. Oddis’ career and his legacy to ASHP:

  • Joined ASHP in 1960 as Executive Secretary, later to be renamed Chief Executive Officer.
  • Leading ASHP’s growth from 3300 members and a staff of 1 (himself!) to 31,000 members and a staff of 180.
  • Developing a staff culture that focuses on serving our members in a respectful, team-based approach, with a commitment to excellence.
  • Growing ASHP’s education services, launching the national meetings that would become the ASHP Summer Meeting and the ASHP Midyear Clinical Meeting, now the largest meeting of pharmacists in the world.
  • Building upon ASHP’s early support of international efforts to improve pharmacy practice, including serving as president of FIP from 1986 – 1990.
  • Improving pharmacy practice and raising the visibility and status of ASHP by recognizing the importance of practice standards. Under Dr. Oddis’ stewardship, ASHP worked with practitioners to develop and publish nearly 100 practice standards, guidelines, technical assistance bulletins, and position papers.
  • Helping promote the concept of formularies and the acceptance of pharmacy and therapeutics (P&T) committees in the early 1960s by building consensus among key stakeholders, including the American Hospital Association, the American Medical Association, the American Pharmacists Association, and ASHP.  In 1965, Medicare based its standards on ASHP’s statements and standards and The Joint Commission deemed an active P&T committee essential for hospital accreditation.
  • Establishing ASHP’s pharmacy residency accreditation program, now celebrating its 50th anniversary. Today, ASHP has 1,582 pharmacy residency programs and 246 pharmacy technician training programs in the accreditation process. In 2012, there were more than 2,500 residents in a PGY1 or PGY2 residency program.
  • Creating the ASHP Research and Education Foundation, which today offers extensive research grant, educational, and awards programs that assist and recognize pharmacists providing care to patients in our nation’s hospitals and health systems, leading to optimal medication outcomes.
  •  Expanding ASHP’s publishing efforts:
    • Introducing the American Hospital Formulary Service (AHFS), which has gained national recognition as the most comprehensive resource of unbiased drug information, and recognized by the U.S. Congress as an official compendium.
    • Introducing International Pharmaceutical Abstracts (IPA), which was published by ASHP from 1964 to 2004.
    • 1964 publication of Mirror to Hospital Pharmacy, which has developed into the ASHP National Survey of Hospital and Health-System Practice.
  • Building ASHP’s leadership and influence by collaborating with other pharmacy and health care organizations and government regulatory agencies on the important issues of the time, including the American Hospital Association, the American Nurses Association, the American Society of Internal Medicine, The Joint Commission, the Food and Drug Administration, and the agency that administered Medicare, among others.

Please join me in thanking Dr. Oddis for his dedication to ASHP and the profession of pharmacy.

 

Powered by WordPress